MicroRNA‐139 is a predictor of prostate cancer recurrence and inhibits growth and migration of prostate cancer cells through cell cycle arrest and targeting IGF1R and AXL

MiR-139-5p suppresses osteosarcoma cell growth and invasion through regulating DNMT1

(2018) Yong-Kang Shi et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Tumor-suppressor role of miR-139-5p in endometrial cancer

(2018) JinHui Liu et al.   Cancer Cell International

Axl inhibitors as novel cancer therapeutic agents

(2018) Yingying Shen et al.   LIFE SCIENCES

Targeting Gas6/TAM in cancer cells and tumor microenvironment

(2018) Guiling Wu et al.   Molecular Cancer

miR-139-5p inhibits aerobic glycolysis, cell proliferation, migration, and invasion in hepatocellular carcinoma via a reciprocal regulatory interaction with ETS1

(2018) Shengni Hua et al.   ONCOGENE

MicroRNA-652 induces NED in LNCaP and EMT in PC3 prostate cancer cells

(2018) Robert K. Nam et al.   Oncotarget

Targeting the Notch1 oncogene by miR-139-5p inhibits glioma metastasis and epithelial-mesenchymal transition (EMT)

(2018) Jianlong Li et al.   BMC Neurology

LINC00152 promotes the growth and invasion of oral squamous cell carcinoma by regulating miR-139-5p

(2018) Minghe Li et al.   OncoTargets and Therapy

MicroRNA-139 inhibits the proliferation and migration of osteosarcoma cells via targeting forkhead-box P2

(2017) Chunan Zhong et al.   LIFE SCIENCES

MicroRNA-139-5p Inhibit Cell Proliferation and Invasion by Targeting RHO-Associated Coiled-Coil Containing Protein Kinase 2 in Ovarian Cancer

(2017) Yanli Wang et al.   ONCOLOGY RESEARCH

MicroRNA-139-5p inhibits bladder cancer proliferation and self-renewal by targeting the Bmi1 oncogene

(2017) Hongbo Luo et al.   TUMOR BIOLOGY

Micrornas in prostate cancer: an overview

(2017) Daniela Vanacore et al.   Oncotarget

Yes-Associated Protein 1 Promotes Adenocarcinoma Growth and Metastasis through Activation of the Receptor Tyrosine Kinase Axl

(2017) Z-L. Cui et al.   INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY

MicroRNA-139-5p regulates proliferation of hematopoietic progenitors and is repressed during BCR-ABL-mediated leukemogenesis

(2016) J. Choi et al.   BLOOD

Dual Role of p21 in the Progression of Cancer and Its Treatment

(2016) Amna Parveen et al.   CRITICAL REVIEWS IN EUKARYOTIC GENE EXPRESSION

MiR-301a regulates E-cadherin expression and is predictive of prostate cancer recurrence

(2016) Robert K. Nam et al.   PROSTATE

MiR-139-5p inhibits the biological function of breast cancer cells by targeting Notch1 and mediates chemosensitivity to docetaxel

(2015) He-da Zhang et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

AXL Mediates Resistance to PI3Kα Inhibition by Activating the EGFR/PKC/mTOR Axis in Head and Neck and Esophageal Squamous Cell Carcinomas

(2015) Moshe Elkabets et al.   CANCER CELL

The insulin-like growth factor (IGF) axis as an anticancer target in prostate cancer

(2015) Isabel Heidegger et al.   CANCER LETTERS

miRWalk2.0: a comprehensive atlas of microRNA-target interactions

(2015) Harsh Dweep et al.   NATURE METHODS

IGF-1R Signaling Is Essential for the Proliferation of Cultured Mouse Spermatogonial Stem Cells by Promoting the G2/M Progression of the Cell Cycle

(2015) Si Wang et al.   STEM CELLS AND DEVELOPMENT

Identification and Validation of a Five MicroRNA Signature Predictive of Prostate Cancer Recurrence and Metastasis: A Cohort Study

(2015) Robert K. Nam et al.   Journal of Cancer

Oncogenic functions of IGF1R and INSR in prostate cancer include enhanced tumor growth, cell migration and angiogenesis

(2015) Isabel Heidegger et al.   Oncotarget

Overdiagnosis and Overtreatment of Prostate Cancer

(2014) Stacy Loeb et al.   EUROPEAN UROLOGY

Axl receptor tyrosine kinase is a novel target of apigenin for the inhibition of cell proliferation

(2014) KYUNG-CHAN KIM et al.   INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE

Oxidative stress-induced cyclin D1 depletion and its role in cell cycle processing

(2013) Chul-Woong Pyo et al.   BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS

TAZ Expression as a Prognostic Indicator in Colorectal Cancer

(2013) Hiu-Fung Yuen et al.   PLoS One

Tumor-Suppressive Function of miR-139-5p in Esophageal Squamous Cell Carcinoma

(2013) Ran Liu et al.   PLoS One

miR-139-5p is a regulator of metastatic pathways in breast cancer

(2013) K. Krishnan et al.   RNA

Axl is essential for VEGF-A-dependent activation of PI3K/Akt

(2012) Guo-Xiang Ruan et al.   EMBO JOURNAL

The receptor tyrosine kinase Axl is an essential regulator of prostate cancer proliferation and tumor growth and represents a new therapeutic target

(2012) J D Paccez et al.   ONCOGENE

PTEN Deletion in Prostate Cancer Cells Does Not Associate with Loss of RAD51 Function: Implications for Radiotherapy and Chemotherapy

(2011) M. Fraser et al.   CLINICAL CANCER RESEARCH

Candidate microRNA biomarkers in human colorectal cancer: Systematic review profiling studies and experimental validation

(2011) Yanlei Ma et al.   INTERNATIONAL JOURNAL OF CANCER

Plasma and tissue insulin-like growth factor-I receptor (IGF-IR) as a prognostic marker for prostate cancer and anti-IGF-IR agents as novel therapeutic strategy for refractory cases: A review

(2011) Emine Elif Ozkan   MOLECULAR AND CELLULAR ENDOCRINOLOGY

Overexpression of receptor tyrosine kinase Axl promotes tumor cell invasion and survival in pancreatic ductal adenocarcinoma

(2010) Xianzhou Song et al.   CANCER

The MicroRNA miR-139 Suppresses Metastasis and Progression of Hepatocellular Carcinoma by Down-regulating Rho-Kinase 2

(2010) Carmen Chak–Lui Wong et al.   GASTROENTEROLOGY

Myeloid Zinc Finger 1 Induces Migration, Invasion, and In vivo Metastasis through Axl Gene Expression in Solid Cancer

(2010) G. Mudduluru et al.   MOLECULAR CANCER RESEARCH

Differential expression of Axl in hepatocellular carcinoma and correlation with tumor lymphatic metastasis

(2010) Ling He et al.   MOLECULAR CARCINOGENESIS

AXL regulates mesothelioma proliferation and invasiveness

(2010) W-B Ou et al.   ONCOGENE

Vimentin regulates EMT induction by Slug and oncogenic H-Ras and migration by governing Axl expression in breast cancer

(2010) K Vuoriluoto et al.   ONCOGENE

Cyclin D1 Degradation Is Sufficient to Induce G1 Cell Cycle Arrest despite Constitutive Expression of Cyclin E2 in Ovarian Cancer Cells

(2009) C. P. Masamha et al.   CANCER RESEARCH

DIXDC1 targets p21 and cyclin D1 via PI3K pathway activation to promote colon cancer cell proliferation

(2009) Lei Wang et al.   CANCER SCIENCE

Gas6 and the Receptor Tyrosine Kinase Axl in Clear Cell Renal Cell Carcinoma

(2009) Anna Gustafsson et al.   PLoS One

Axl is an essential epithelial-to-mesenchymal transition-induced regulator of breast cancer metastasis and patient survival

(2009) C. Gjerdrum et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

MicroRNAs and their potential for translation in prostate cancer

(2009) Ralph W. deVere White et al.   UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS

Phosphorylation of Cyclin D1 Regulated by ATM or ATR Controls Cell Cycle Progression

(2008) M. Hitomi et al.   MOLECULAR AND CELLULAR BIOLOGY

Prostate cancer genomics: towards a new understanding

(2008) John S. Witte   NATURE REVIEWS GENETICS